Gilead Hiv Drugs
Gilead Sciences Inc GILDO on Thursday said its first-quarter product sales rose 16 including 146 billion in sales of its COVID-19 antiviral drug remdesivir but sales of flagship HIV and. Gilead said the COVID-19 pandemic continued to hurt sales of its treatments for hepatitis C and HIV due to fewer people going to their doctors during the pandemic. Patients Sue Gilead Saying Drug Company Intentionally Delayed Safer Hiv Medicine Los Angeles Times Lawsuits will allege that Gilead Sciences withheld releasing a safer variation of TDF tenofovir alafenamide fumarate TAF. Gilead hiv drugs . TDF Drugs by Gilead TDF HIV Medications at the Center of Litigation. Gilead is a member of the NASDAQ Biotechnology Index and the SP 500. HHS alleges that its patents have been infringed by Gilead through two drugs indicated for treating HIV-1 infection as well as PrEP. Truvada Viread Atripla Complera Stribild. But thousands of people living with HIV have allegedly complained of kidney and bon